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1. Introduction 
The global incidence and prevalence of obesity increase with every passing year, affecting 
both developed and developing countries. An appalling estimate of 75% of adults are 
projected to be overweight or obese in the United States by 2015 (Wang and Beydoun, 2007), 
thus raising serious concerns regarding the social and economic repercussions of obesity. 
The etiology of obesity is complex, with both genetic and environmental factors influencing 
its susceptibility and development (Campion et al., 2009; Russo et al., 2010). The detrimental 
effect of obesity on metabolic, cardiovascular and central nervous system dysfunction is 
well documented, as is its association with type 2 diabetes and cancer (Andersson et al., 
2008; Bruce-Keller et al., 2009; Gallagher and LeRoith, 2010). 
The continuing study of the adipose tissue over the past  twenty years has transformed the 
perception that most investigators had of that organ. Despite being considered for decades 
no more than an uninteresting container for the storage of spare energy endowed with some 
useful mechanical and thermal insulating characteristics, the white adipose tissue (WAT) is 
actually an extremely dynamic endocrine organ that secretes a wide variety of hormones 
and cytokines, some of them in exclusivity, such as adiponectin (Zhang et al., 1994; Scherer 
et al., 1995; Kershaw and Flier, 2004; Trayhurn and Wood, 2004). Well over fifty adipokines 
have been described to date, with pleiotropic functions that highlight the involvement of the 
adipose tissue in the regulation of processes as varied as insulin sensitivity and glucose 
homeostasis, blood pressure, angiogenesis, fertility, immunity, neuroplasticity or 
inflammation (Trayhurn and Wood, 2004; Dietrich and Horvarth, 2009; Galic et al., 2010).   
Obesity is defined by excess accumulation of white adipose mass, resulting from both an 
increase in adipocyte cell size (hypertrophy) and the development of new mature cells from 
undifferentiated precursors (hyperplasia) (Heine et al., 2000; Naaz et al., 2004). Serum levels 
of most adipokines increase with obesity, whereas others, notably adiponectin, decrease, 
upsetting the energetic balance of the organism (Trayhurn and Wood, 2004; Smith et al., 
2006). Most importantly, the enlarged obese adipose tissue displays enhanced macrophage 
infiltration and behaves as a chronically inflamed organ (Weisberg et al., 2003; Xu et al., 
2003). 
The process of inflammation has evolved as a mechanism to repair a tissue after infection or 
physical damage has taken place. The acute inflammatory response is a controlled process 
initiated by tissue resident macrophages that after detecting infection or injury secrete a 
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variety of inflammatory mediators that on the one hand attract leukocytes and platelets to 
the affected site, and on the other hand activate the endothelial cells, increasing their 
permeability to leukocytes (specifically neutrophils) while avoiding extravasation of 
erythrocytes (Medzhitov, 2008). The concluding stage of inflammation is resolution, 
mediated mainly by the tissue resident macrophages that secrete anti-inflammatory 
mediators to inhibit further recruitment of neutrophils while favoring that of monocytes that 
remove dead cells and participate in tissue repair and remodeling (Medzhitov, 2008). If 
resolution is not forthcoming, chronic inflammation ensues, ultimately resulting in tissue 
damage and metabolic demise of the organism. 
Obesity is nowadays being accepted as a state of chronic low-grade inflammation (Xu et al., 
2003; Weisberg et al., 2006). This inflammatory state impacts the function of many organs 
and tissues, from the adipose tissue itself to the endothelium, the central nervous system, 
the pancreas or the liver, and is being recognized as etiological of the aging process. 
2. The proinflammatory features of dysfunctional obese adipose tissue 
The white adipose tissue is constituted by a mixture of cell types, amongst which mature 
adipocytes represent the main fraction. Fat cell number is settled during adolescence or 
early adulthood in humans, but at least 10% of the total adipose mass is renewed every year 
(Spalding et al., 2008). In fact, recent reports indicate that 1-5% of total adipocytes may be 
replaced each day (Rigamonti et al., 2011). Mature adipocytes differentiate from progenitors, 
i.e. preadipocytes, which are present in the stromal-vascular fraction of the tissue that also 
contains, together with other minority cell types, a variable number of resident 
macrophages/monocytes (Rodeheffer et al., 2008). In physiological conditions, macrophages 
in WAT display an alternatively activated M2 phenotype, characterized by secretion of anti-
inflammatory cytokines such as IL-10 (Lumeng et al., 2007; Olefsky and Glass, 2010). 
However, the cellular composition of WAT is altered in obesity (Figure 1). 
On the one hand, the number of committed preadipocytes capable of undergoing 
adipogenesis is reduced in obese individuals (Tchoukalova et al., 2004; Tchoukalova et al., 
2007; Isakson et al., 2009). Conversely, the number of infiltrated macrophages is significantly 
increased in obesity. Macrophages may represent as much as a 30 % of the total obese 
adipose tissue cell population, as compared to a 10 % in lean tissue, in both human and 
rodent models (Weisberg et al., 2003; Xu et al., 2003). Moreover, macrophages infiltrating the 
obese adipose tissue switch to a classically activated M1 phenotype (Lumeng et al., 2007), 
resulting in enhanced proinflammatory cytokine production and systemic low-grade 
inflammation arising from the adipose tissue (Olefsky and Glass, 2010).  
Obesity-associated inflammation has been linked to the development of major complications 
in acute pancreatitis (Evans et al., 2010), non-alcoholic fatty liver disease (Tilg, 2010), 
vascular inflammation and coronary artery disease (Andersson et al., 2008; Gomes et al., 
2010), chronic obstructive pulmonary disease (Tkacova, 2010), risk of cerebral ischemia and 
brain injury (Denes et al., 2010) and atherosclerotic vascular disease and myocardial 
infarction (Ohman et al., 2009). Moreover, preclinical data suggest a link between obesity 
and cancer (Hursting et al., 2008; Roberts et al., 2010). In fact, it has been estimated that 
overweight and obesity account for approximately 20 % of all cancer cases and scattered 
evidence indicates beneficial effects of weight loss on susceptibility and prognosis of some 
types of cancer (Wolin et al., 2010). This inflammatory state also underlies obesity-associated 
insulin resistance, and genetic inactivation of several inflammatory mediators or their 
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receptors in macrophages improves insulin action and may prevent the development of 
diabetes in animal models (Arkan et al., 2005; Weisberg et al., 2006; Solinas et al., 2007). 
 
Fig. 1. The cellular composition of the adipose tissue is altered in obesity. Lean adipose 
tissue is composed of mature adipocytes and the stromal vascular cell fraction characterized 
by presence of adipose tissue stem cells, committed preadipocytes, endothelial cells and 
tissue resident macrophages with an alternatively activated M2 phenotype, which secrete 
anti-inflammatory IL-10. Adipocytes secrete leptin and adiponectin amongst other adipose 
tissue hormones. The obese adipose tissue is characterized by enlarged adipocytes that 
secrete increased levels of leptin giving rise to central and peripheral leptin resistance, and 
decreased levels of anti-inflammatory adiponectin. Macrophages infiltrate the obese adipose 
tissue in high numbers and polarize to a classically activated M1 phenotype, increasing 
secretion of proinflammatory cytokines such as TNF- or IL-6. The inflammatory 
environment activates the preadipocytes that then acquire macrophage-like characteristics 
by expressing high levels of inflammatory cytokines and being unable to differentiate. 
3. Epigenetics of inflammation  
The concept of epigenetics refers to the study of cellular mechanisms that control 
somatically, and sometimes intergenerationally, inheritable gene expression states that are 
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established in the absence of a change in the DNA sequence itself. Epigenetic mechanisms 
comprise an array of molecular modifications to both the DNA molecule itself and the 
histone proteins that associate with it, as well as the regulation by non-coding RNAs 
(Bernstein et al., 2007). Epigenetic processes drive the response of the cells to environmental 
cues by selectively activating or repressing transcription of subsets of genes and thus play a 
crucial role in regulating the transcriptional state and functionality of cells during 
development or in physiological and pathological conditions. Together with the genetic 
background (gene variants, polymorphisms) of an individual, the epigenetic modifications 
accumulated in the course of a lifetime of environmental influences dictate the susceptibility 
to and development of disease (Fraga et al., 2005; Poulsen et al., 2007). Remarkably, recent 
findings indicate that inflammation induces epigenetic alterations in tissues that then lay the 
basis for later disease manifestation (Backdahl et al., 2009).  
Two of the most studied epigenetic mechanisms are DNA methylation and the post-
translational modifications of histones. DNA methylation is the process by which a cytosine 
residue present in a CpG dinucleotide is methylated by a DNA methyltransferase (Dnmt) 
enzyme (Gruenbaum et al., 1981). Methylation of CpGs located close to promoters usually 
results in gene silencing and plays a crucial role in developmental processes. Recent data 
have shown that DNA methylation is in some instances dependent on the pattern of histone 
post-translational modifications in the same gene region and vice versa (Fuks, 2005). Histone 
modifications create new binding sites for regulatory proteins, thus resulting in recruitment 
of specific activator/repressor complexes (Bartke et al., 2010; Oliver and Denu, 2011). 
Numerous reports have shown a clear link between the pattern of histone modifications in 
the chromatin of a given gene and its transcriptional status, and this has been considered 
indicative of the existence of a histone code, where the pattern of histone modifications at a 
gene region regulates the transcriptional outcome, as well as other DNA-based processes 
such as replication or DNA repair, either by modulating access to the DNA or by actively 
recruiting transcriptional regulators (Strahl and Allis, 2000; Turner, 2000; Jenuwein and 
Allis, 2001). In this regard, histone lysine acetylation is usually related to gene activation 
(Pokholok et al., 2005), whereas methylation results in different outcomes, depending on the 
modified residue (Lachner et al., 2001; Santos-Rosa et al., 2002; Talasz et al., 2005). Histone 
acetylation is the result of the interplay between histone acetyltransferases (HATs) and 
deacetylases (HDACs), whereas the enzymes responsible for histone methylation turnover 
are the histone methytransferases (HMTs) and demethylases (HDMs) (Couture and Trievel, 
2006; Smith and Denu, 2009). Interestingly, many components of the basic transcriptional 
machinery and transcription factors can also undergo acetylation or metylation, which may 
in turn regulate their activity (Imhof et al., 1997; Egorova et al., 2010).  
Non-coding RNAs (ncRNAs), on the other hand, are a large group of RNA molecules that 
are not translated into protein (Bernstein and Allis, 2005). Recent findings have unravelled a 
critical role for some of these RNA molecules, such as microRNAs (miRNAs), in the 
regulation of gene expression and genomic stability. miRNAs are 18-24 nucleotide long, 
single-stranded RNA molecules that suppress the expression of protein-coding mRNAs, 
either by directing translational repression or mRNA desestabilization (Bernstein and Allis, 
2005).  
DNA methylation, histone modifications and miRNAs play key roles in the differentiation 
of adipocytes and participate in the development of obesity (Esau et al., 2004; Fu et al., 2005; 
Musri et al., 2006; Noer et al., 2006; Yoo et al., 2006; Musri et al., 2007; Lee et al., 2008; Cho et 
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al., 2009; Horii et al., 2009; Inagaki et al., 2009; Tang et al., 2009; Wakabayashi et al., 2009; 
Heneghan et al., 2010; Musri et al., 2010; Yang et al., 2010). Epigenetic processes are also 
implicated in the physiological and pathological inflammatory response (Bayarsaihan, 2011). 
Increased transcription of proinflammatory cytokine genes by master regulator NF- is 
associated with enhanced histone acetylation at their promoters (Yamamoto et al., 2003), as 
well as phosphorylation of Ser10 of histone H3 (H3Ser10) (Anest et al., 2003; Yamamoto et 
al., 2003). NF- regulatory kinase IKK- can in fact phosphorylate H3Ser10 in vitro (Anest 
et al., 2003). On the other hand, expression of NF- itself in monocytes or neutrophils is 
regulated by several miRNAs, such as miR-9, whose expression is in its turn regulated by 
NF-, thus establishing a feedback loop that may control the degree of inflammation 
(Bazzoni et al., 2009). Dysregulation of any of these processes could generate an anomalous 
persistence of the inflammatory response in time, resulting in metabolic alterations and 
tissue damage. 
4. Impact of inflammation on the adipose tissue 
Several hypotheses have been proposed in an attempt to explain the role of the adipose 
tissue in the metabolic dysfunction associated with obesity. Thus, the altered pattern of 
adipokine secretion by the obese adipose tissue (Ukkola and Santaniemi, 2002; Tataranni 
and Ortega, 2005;), the inflammatory state associated with obesity (Cottam et al., 2004), or 
the inability of the adipose tissue to expand its mass in response to increased energy intake 
(Virtue and Vidal-Puig, 2010) have all been signaled as possible culprits. However, all these 
different hypotheses are not mutually exclusive. 
Inflammation of the adipose tissue has been proposed as the critical element that 
distinguishes metabolically ‘healthy’ from ‘unhealthy’ obese subjects (Bluher, 2010), and a 
recent study has reported that increased inflammation in the adipose tissue precedes the 
development of obesity and insulin resistance in mice (Mori et al., 2010). Interestingly, 
preadipocytes display many functional and antigenic features in common with the 
monocyte/macrophage lineage and can actually be converted into macrophages given the 
adequate environment (Charriere et al., 2003). In fact, inflammatory cytokines such as tumor 
necrosis factor (TNF)- and interleukin 6 (IL-6) block adipogenesis (Gustafson and Smith, 
2006) and induce the expression and secretion of molecules that are not usually secreted by 
preadipocytes, such as IL-1, IL-6 itself or the monocyte chemoattractant protein MCP-1 
(Isakson et al., 2009). Therefore, inflammation has a double-hit effect on adipose tissue 
dysfunction by on the one hand decreasing adipogenesis and consequently cell turnover 
and expandability potential, and on the other increasing cytokine production thus 
establishing a self-sustaining cycle. Epigenetic mechanisms probably underlay this 
phenotype. In fact, overexpression of DNA methyltransferase Dnmt3a in mouse adipocytes 
results in enhanced expression of proinflammatory genes by the obese adipose tissue 
(Kamei et al., 2010). Obesity caused by high-fat diet increases DNA methylation at the leptin 
promoter in rat adipocytes, and this is associated with decreased circulating leptin levels 
(Milagro et al., 2009). Inflammatory cytokines such as TNF- provoke wide transcriptomic 
changes in adipose tissue in vivo and in vitro (Ruan et al., 2002b; Isakson et al., 2009). In 
particular, TNF- induces expression of the pseudokinase Tribbles 1 (Trb1) in mature 
adipocytes. Trb1 then binds to NF- target promoters and favors transcription of 
proinflammatory genes (Ostertag et al., 2010), thus creating a vicious circle. On the other 
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hand, incubation of differentiated adipocytes in the presence of TNF- suppresses 
expression of mature adipocyte genes, and reactivates the expression of those characteristic 
of the preadipocyte stage (Ruan et al., 2002a). Obesity produces the same effect, thus 
suggesting that the changes observed in obese adipose tissue are due to the 
proinflammatory environment (Xie et al., 2009). Moreover, obesity alters the pattern of 
adipose tissue-expressed miRNAs in the same fashion, by suppressing expression of mature 
adipocyte miRNAs, such as miR-103 or mir-143, while reactivating the expression of those 
highly expressed in preadipocytes, including miR-221 and miR-222, (Xie et al., 2009). 
Expression of miR-222 is also increased in 3T3-L1 adipocytes maintained under 
hyperglycemic conditions (Herrera et al., 2010) or in adipose tissue of mice treated with 
conjugated linoleic acid (Parra et al., 2010), indicating that it is involved in the 
pathophysiology of diabetes. Interestingly, a number of miRNAs play crucial functions in 
both the adipose tissue and the immune system. Thus, the miR-17~92 cluster accelerates 
adipogenesis in 3T3-L1 cells (Wang et al., 2008) and blocks monocytic differentiation of 
human CD34+ hematopoietic progenitor cells (Fontana et al., 2007), although this later effect 
is not seen in vivo in two different mouse models (Ventura et al., 2008; Xiao et al., 2008). 
Incidentally, however, no effect of miR-17~92 deficiency on the adipose tissue has been 
reported to date.  
5. Impact of inflammation on the endothelium 
Endothelial damage and associated increased cardiovascular risk is a fixture of obesity 
(Andersson et al., 2008). Endothelial cells incubated in the presence of preadipocytes treated 
with proinflammatory cytokines as compared with control preadipocytes express high 
levels of those cytokines themselves and display increased monocyte adhesion to them 
(Mack et al., 2009). 
The regulatory role of epigenetic mechanisms in the pathogenesis of atherosclerosis and risk 
of coronary artery disease and stroke is increasingly being recognized (Wierda et al., 2010). 
Recent studies have shown that histone methylation is involved in establishing and 
maintaining the activated proinflammatory state of vascular smooth muscle cells (VSMC) in 
diabetic obese db/db mice. Histone methyltransferase Suv39h1 is required to maintain high 
levels of repressive trimethylation of the lysine K9 of the histone H3 (H3K9me3) at the 
promoters of inflammatory genes in these cells (Villeneuve et al., 2008). In diabetic mice, 
expression of miR-125b increases in VSMCs and this results in decreased expression of its 
target Suv39h1 and thus decreased H3K9me3 methylation at the promoters of 
proinflammatory genes, coupled with increased gene expression (Villeneuve et al., 2010). 
Similarly, histone demethylase LSD1 is decreased in db/db VSMCs, resulting in increased 
H3K4me2 levels and enhanced expression of inflammatory genes ccl2 and il6  (Reddy et al., 
2008).  
The key proinflammatory transcription factor NF- is upregulated in endothelial cells as a 
response to hyperglycemia in vitro, and this is associated with binding of LSD1 and histone 
methyltransferase Set7 to its promoter and increased H3K4me1 methylation (Brasacchio et 
al., 2009). In its turn, NF- also associates with Set7 to stimulate transcription of its target 
genes in monocytes, and Set7 binding to proinflammatory promoters increases in 
macrophages from diabetic mice (Li et al., 2008). Interestingly, one of the genes whose 
expression is increased by NF- and Set7 in macrophages treated with TNF- is the 
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histone demethylase JMJD3 (Li et al., 2008), thus suggesting a mechanism by which 
proinflammatory cytokines induce expression of chromatin-modifying enzymes in target 
cells to remodel chromatin and amplify the inflammatory response.  
The expression of a number of miRNAs is also altered in endothelial cells incubated under 
inflammatory conditions (Dentelli et al., 2010). Expression of miR-222, for instance, is 
downregulated in endothelial cells exposed to inflammatory stimuli and its expression is 
negatively correlated with inflammation-mediated vascular remodeling through regulation 
of its target Signal Transducer and Activator of transcription 5A (STAT5A) (Dentelli et al., 
2010). Treatment with Angiotensin II (Ang II) also has been shown to decrease the 
expression of miR-221/222 as well as miR-155 in human umbilical vein endothelial cells 
(HUVEC), and this decrease is associated with increased expression of their target Ets-1, a 
transcription factor that regulates the expression of adhesion molecules in endothelial cells 
(Zhu et al., 2011). Overexpression of miR-221/222 and miR-155 in HUVEC effectively 
decreased the adhesion of Jurkat T cells to Ang II-treated HUVEC (Zhu et al., 2011). 
Increased expression of adhesion molecules E-selectin and ICAM1 in endothelial cells 
treated with TNF- is also mediated through changes in the expression of miRNAs such as 
miR-31 or miR-17-3p (Suarez et al., 2010).  
6. Obesity and aging  
Healthy aging and longevity are negatively influenced by inflammatory processes and 
metabolic alterations. The longevity phenotype seems to arise from a complex network of 
genetic, epigenetic and environmental factors interacting through still poorly characterized 
pathways. A negative relationship between adiposity and longevity has been recently 
proposed in an epidemiological study in healthy centenarians which revealed that low body 
fat mass, a nonatherogenic lipid profile and a better insulin sensitivity correlate with human 
longevity (Bluher, 2008). Moreover, telomere length, which is a marker of cellular 
senescence dependent of intricate epigenetic mechanisms, has recently been found to be 
decreased in human subjects with higher total and abdominal adiposity, further reinforcing 
the notion that obesity may accelerate the aging process (Lee et al., 2011).  
Most of the longevity gene candidates described so far are related either to inflammatory 
functions, lipid and glucose metabolism or the stress response. Indeed, aging is 
characterized by chronic low-grade inflammation termed "inflammaging", in which a two- 
to fourfold increase in proinflammatory cytokines and acute phase protein production is 
observed (Jylhävä and Hurme, 2010). Notably, preadipocytes, which as mentioned are 
closely related to macrophages, dedifferentiate with aging and switch to a proinflammatory, 
senescent-like state (Tchkonia et al., 2010). However, a senescent-like state also develops in 
fat cells and preadipocytes from young obese subjects (Villaret et al., 2010). 
Changes in DNA methylation levels and histone modification patterns have been detected 
throughout life although their effect on aging is only just beginning to be revealed 
(Siegmund et al., 2007; Dang et al., 2009; Greer et al., 2010; Siebold et al., 2010). Whether 
the age-dependent epigenetic drift is boosted by pathological metabolic situations such as 
obesity-related inflammation remains an unexplored territory. However, several 
observations point to a role for epigenetics in the regulation of lipid metabolism, 
inflammation and longevity. In organisms ranging from yeast to mammals, leanness and 
caloric restriction have been shown to increase longevity through the class III histone 
deacetylase sirtuin 1 (SIRT1), which acts in several cell processes by deacetylating both 
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histones and transcription factors. A putative role for sirtuins as metabolic or oxidative 
sensors that respond to the cellular environment has been proposed (Frye et al, 1999). 
Interestingly, a potential protective role of SIRT1 against the metabolic consequences of 
chronic exposure to a high-fat diet has been recently described in a transgenic SIRT1 
mouse model (Pfluger et al., 2008). Mice overexpressing SIRT1 and fed a high fat diet 
showed lower lipid-induced inflammation along with better glucose tolerance, and almost 
entire protection from hepatic steatosis compared with wild type controls. Such beneficial 
effects of SIRT1 correlated with increased expression of antioxidant proteins MnSOD and 
Nrf1 and reduced expression of proinflammatory cytokines, such as TNF- and IL-6, 
probably by inhibiting NF-K activity. Consistent with these observations, the AMP-
activated protein kinase AMPK, acting through SIRT1 negatively regulates lipid-induced 
inflammation, indicating that this protein deacetylase may exert its anti-aging function at 
least in part through protection against obesity, inflammation, and insulin resistance 
(Yang et al., 2010). Interestingly, it has been shown that the natural compound resveratrol 
has anti-inflammatory effects in human adipose tissue through the SIRT1 pathway 
(Olholm et al., 2010) and several studies have described its capacity to extend lifespan in 
different species (i.e. S. cerevisae, C. elegans, and D. melanogaster) also through the sirtuin 
pathway, although other studies did not find an effect of resveratrol on lifespan. 
(Mouchiroud et al., 2010).  
7. Obesity and the central nervous system 
In a prospective cohort study conducted from 1997 to 2002 of 3075 subjects aged 70 to 79 
years, an increased rate of cognitive decline was detected in those with high levels of serum 
markers of inflammation (Yaffe et al, 2004). Indeed, subclinical inflammation seems to be 
involved in the pathogenesis of cognitive impairment. Increased body mass and obesity 
have been related to cognitive decline, including decreased attentional performance, speed 
of processing and executive functions (Gunstad et al., 2007; Boeka et al, 2008; Fergenbaum et 
al, 2009). Moreover, midlife obesity is increasingly being described as a dementia risk factor 
in later life (Fitzpatrick et al, 2009). Reductions in brain volume in frontal, temporal, parietal, 
and occipital lobes, gray matter in temporal and frontal regions and white matter have been 
associated with obesity (Pannacciulli et al., 2006; Gunstad et al., 2008; Taki et al., 2008; 
Volkow et al., 2009; Ho et al., 2010; Stanek et al, 2011). 
Neural oxidative stress, inflammation, and NF- activation have been detected in cerebral 
cortex from rats fed a high fat diet (Zhang et al 2005), suggesting a link between diet-induced 
obesity and increased risk of dementia. This can be due, at least in part ,to triglyceride 
breakdown into free saturated fatty acids such as palmitic acid and lauric acid, which have 
been shown to modulate astrocytic and microglial signaling and to trigger inflammatory 
signals in macrophages (Patil et al, 2005; Laine et al, 2007). Another mechanism that seems to 
be involved in the peripheral modulation of CNS function is the impairment by triglycerides 
of leptin transport through the blood-brain barrier (Banks et al., 2004).  Leptin is an afferent fat-
to-brain signal entering the brain via a saturable transport mechanism and acting at 
hypothalamic centers to regulate the feeding behavior. In addition to this well characterized 
hypothalamic function, leptin receptors are also widely expressed in other regions of the brain, 
including brain stem, cerebellum, amygdala and hippocampus (Fei et al., 1997; Elmquist et al., 
1998) and a role for leptin in cognitive processes has been proposed (Harvey et al., 2005). For 
example, behavioral performance was improved in rats after intravenous administration of 
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leptin (Oomura et al., 2006).  Notably, leptin has been shown to modulate the inflammatory 
signaling in microglia (Pinteaux et al, 2007; Tang et al, 2007). 
Recently, intergenerational effects of maternal obesity on the CNS have been reported in 
mouse models, sustained at least in part by epigenetic mechanisms. Indeed, maternal 
obesity induced by consumption of a high fat diet prior to and during pregnancy and 
lactation leads to metabolic alterations in the offspring together with behavioral and 
biochemical alterations within their CNS. For example, effects of prenatal and postnatal 
exposure to high fat diet (HFD) on the brain were studied by analyzing pups born to HFD-
induced obese or control diet (CD) mothers (White et al, 2009). After weaning, male progeny 
was placed on a CD until 8 weeks old, and then fed either a HFD or a CD themselves. HFD 
progeny from HFD dams manifested a significantly increased cognitive decline associated 
with significant increases in 3-nitrotyrosine, iNOS, IL-6, and glial markers Iba-1 and GFAP. 
These data suggest that brain oxidative and inflammatory signaling is increased by HFD, 
and that maternal HFD-induced obesity might sensitize offspring. Other studies seem to 
support some of these observations. Diet-induced maternal obesity has recently been 
reported to impair hippocampal BDNF production and spatial cognitive function in young 
offspring, possibly due to metabolic and oxidative changes. (Tozuka et al, 2010). Similarly, 
in a recent report, rats were fed high-fat diets that created an obese phenotype or were 
maintained under a low-fat diet for 4 weeks prior to mating, throughout pregnancy and 
lactation (Bilbo and Tsang, 2010). At birth, pups from obese mothers showed increased 
serum leptin levels and microglial activation markers in the hippocampus. From weaning to 
adulthood, in response to a bacterial challenge (LPS), peripheral proinflammatory cytokines 
were significantly increased in offspring from obese mothers compared to controls. These 
changes were accompanied by higher anxiety levels in the HFD offspring. Although the 
cognitive susceptibility of the offspring from obese mothers to inflammatory insults was not 
evaluated, surprisingly rats born to obese mothers performed better in memory and spatial 
learning tasks than their low fat diet controls, suggesting that exposure to HFD during 
development may lead to different cognitive outcomes than during adulthood (Granholm et 
al., 2008; Murray et al., 2009). On the whole, these data suggest an obesity-induced early life-
programming that may be established by epigenetic mechanisms. 
8. Obesity and cancer  
The connection between obesity and cancer is extensively documented. Obesity has been 
reported as a cause of approximately 14 % of cancer deaths in men and up to 20 % of cancer 
deaths in women in a 25-year-prospective study of U.S. adults (Calle et al.,  2003). In Europe, 
a review by the International Agency for Research on Cancer (IARC) in 2002 concluded that 
obesity was a cause of 39 % of endometrial, 37 % of esophageal, 25 % of kidney, 11 % of 
colon and 9 % of postmenopausal breast cancer cases (International Agency for Research on 
Cancer, 2002). By contrast, being overweight  or obese during childhood and adolescence 
appears to be protective against breast cancer (Ahlgren et al., 2004). Body weight has also 
been inversely associated with breast cancer in premenopausal women (Huang et al, 1997). 
Depending of the type of cancer, different mechanisms have been proposed that can be 
influenced by obesity for example the dysregulation of adipokines. Some of those that 
regulate the immune and the inflammatory response (i.e. leptin, TNF-, IL-6, serum 
amyloid A), seem to contribute to tumorigenesis, tumor progression and metastatic 
potential. Although evidence is still weak, inflammation is a mechanism gaining interest in 
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the cancer field mainly because obesity-related inflammatory markers are increasingly 
associated with worse cancer prognosis (Pierce et al., 2009). Chronic inflammation has been 
linked to initiation and progression of different cancer types, including gastric (Farinati et 
al., 2008), hepatocellular (Fernandez-Irigoyen et al., 2008; Lukasiak et al., 2008), and 
colorectal (Wang & DuBois, 2008) carcinoma. The tumor-associated stroma includes among 
other cell types adipocytes, inflammatory and immune cells and influences the development 
and progression of tumors through its interaction with transformed cells via soluble 
mediators, such as growth factors and cytokines (Mantovani et al., 2008; Ono et al., 2008).  
Other means through which obesity-related chronic inflammation may influence cancer 
development is by altering the host antitumor immune response (Nave et al, 2008) and 
growth factor pathways. Indeed, recent data implicate IGF-I in the obesity-induced increase 
in tumor cell growth and support a critical role of inflammatory cytokines in the regulation 
of hepatic metastasis (Wu et al, 2010). Moreover, leptin, a proinflammatory adipokine 
increased in obesity, can induce eicosanoid production through a PI3K/mTOR-dependent 
pathway and activate resident macrophages to form adipose differentiation-related protein 
(ADRP)-enriched lipid droplets (Maya-Monteiro & Bossa, 2008). Notably, human colon 
adenocarcinoma cell lines and colon cancer biopsies from patients have recently been shown 
to exhibit a drastic increase in ADRP and COX-2-enriched lipid bodies. The pathological 
implications of these changes are supported by data showing that inhibition of lipid droplet 
formation in cancer cells reduces PGE2 production and correlates with diminished cancer 
cell proliferation (Accioly et al., 2008).  
Cells from the white adipose tissue can be recruited by tumors promoting cancer 
progression in mice. WAT cellular types engrafted in tumors include adipose stromal cells 
and adipose endothelial cells and their migration has been attributed to obesity-associated 
inflammation. (Zhang et al., 2009). 
Although evidence for specific epigenetic mechanisms linking obesity-related chronic 
inflammation and cancer is currently lacking, several observations allow a link to be 
hypothesized. It has been proposed that aberrant epigenetic modifications can be induced 
by inflammation early in the process of carcinogenesis and that the accumulation of these 
modifications generates "an epigenetic field for cancerization" (Niwa and Ushijima, 2010). 
Alterations in cytokine and chemokine signaling seem to be involved in inflammation-
induced aberrant DNA methylation. For example, IL-6 promotes the induction of significant 
global DNA hypomethylation as well as CpG promoter methylation changes in putative 
tumor suppressor genes such as CHFR, GATA5 and PAX6 in an in vitro model of 
inflammatory stress in squamous cell carcinoma (OSCC) cell lines (Gasche et al., 2011). 
Disturbances in the activity of DNA methyltransferases are increasingly related to  the 
development of malignant phenotypes and it is interesting to note that the expression of the 
de novo methyltransferase Dnmt3a is increased in the adipose tissue and seems to contribute 
to obesity-related inflammation (Kamei et al., 2010). 
Non-coding RNAs are also part of the cellular epigenetic machinery that regulates cell fate 
and functioning in response to environmental signals. Among them, miRNAs have been 
implicated in the control of a wide variety of biological processes ranging from proliferation 
and apoptosis to metabolism (Krol et al., 2010). Notably, several forms of human tumors 
present a robust upregulation of mir-221 and miR-222, two related miRNAs encoded in 
cluster on chromosome X (Garofalo et al., 2009; Rao et al., 2010; Pu et al, 2010; Zhang et al., 
2010; Pineau et al., 2010; Galardi et al, 2011). Interestingly, miR-221 and miR-222 levels are 
downregulated during adipogenesis but increased in obese adipocytes. These changes have 
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been attributed to the elevated TNF- levels and the overall chronic inflammatory 
environment generated by the obese adipose tissue, as they were mimicked by treatment of 
differentiated 3T3-L1 adipocytes with TNF- (Xie et al, 2009).  
9. Conclusions 
It is becoming increasingly evident that obesity is not only associated with metabolic 
alterations and decreased general wellbeing but it also represents a risk factor for the 
development of other chronic diseases such as cardiovascular disease, central nervous 
system dysfunction, cancer as well as accelerated aging (Figure 2).  
 
 
Fig. 2. Inflammation impacts tissue function and organismal aging. Inflammation causes 
increased macrophage infiltration and decreased adipocyte turnover in the adipose tissue, in 
part due to increased NF- activation, Trb1 expression and alteration of the miRNA profile. 
Overexpression of DNA methyltransferase Dnmt3a in adipose tissue also results in increased 
cytokine expression. In the endothelium inflammation increases expression of proiflammatory 
genes through the regulation of histone demethylases and methyltransferases LSD1, Set7 and 
Suv39h1, as well as miRNA miR-125b which targets Suv39h1. In the central nervous system, 
epigenetic effects of inflammation seem to be mediated by decreased BDNF expression and 
altered leptin signaling. Inflammation also impacts on cell senescence and organismal aging, 
through deregulation of the pattern of DNA methylation and histone deacetylase Sirt1, and in 
cancer initiation and progression, by growth-promoting cytokine signaling and deregulation 
of DNA methylation and the profile of miRNAs. 
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Obesity is now recognized as an inflammatory disease. Inflammation impacts negatively the 
function of many organs and tissues through increased macrophage infiltration and 
decreased adipocyte turnover in the adipose tissue, in part due to increased NF- 
activation and Trb1 expression. Epigenetic mechanisms such as alteration of the miRNA 
profile and overexpression of DNA methyltransferase Dnmt3a in adipose tissue also result 
in increased cytokine expression. In the endothelium, inflammation increases expression of 
proiflammatory genes through the regulation of histone demethylases and 
methyltransferases LSD1, Set7 and Suv39h1, as well as miRNA miR-125b which targets 
Suv39h1. In the central nervous system, epigenetic effects of inflammation seem to be 
mediated by decreased BDNF expression and altered leptin signaling. Inflammation also 
impacts on cell senescence and organismal aging, through deregulation of the pattern of 
DNA methylation and histone deacetylase Sirt1. Inflammation may also affect cancer 
initiation and progression through growth-promoting cytokine signaling and deregulation 
of DNA methylation and the profile of miRNAs. The emerging picture of potential long 
lasting systemic alterations induced by obesity-related inflammation, some of which could 
be transmitted to subsequent generations, raises the urgent need to implement educative, 
preventive and therapeutic approaches to this serious health concern.  
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